Owing to this, >80% of cancer cells are considered to have a constitutively activated Ras/MEK pathway.20,22–24 This suggests that the Ras/MEK pathway plays a critical role in defining the cancer cell sensitivity to 5-ALA-PDT in a broad range of tumours regardless of their type or origin. The gene discussed is MAP2K7; the disease is neoplasm.